ICL Israel Chemicals Ltd (ICL) — Defensive Interval Ratio
ICL Israel Chemicals Ltd (ICL) has a Defensive Interval Ratio of 183 days as of December 2025. Defensive assets of ILA1.57 Billion (cash ILA-, short-term investments ILA205.00 Million, receivables ILA1.36 Billion) cover 183 days of daily cash needs of ILA8.58 Million/day. Check ICL goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ICL Israel Chemicals Ltd Defensive Interval Ratio (2000–2025)
This chart shows how ICL Israel Chemicals Ltd's Defensive Interval Ratio has evolved across 26 annual periods from 2000 to 2025. As of December 2025, the ratio stands at 183 days, meaning defensive assets of ILA1.57 Billion can fund 183 days of operations without new revenue. Also explore ICL net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for ICL Israel Chemicals Ltd (2000–2025)
The table below presents the year-by-year Defensive Interval Ratio for ICL Israel Chemicals Ltd from 2000 to 2025, covering 26 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ICL market cap overview.
| Year | DIR (days) | Defensive Assets (ILA) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 183 days | ILA1.57 Billion | ILA8.58 Million/day | ILA- | ILA205.00 Million | ▼ -64 days |
| 2024 | 247 days | ILA1.58 Billion | ILA6.38 Million/day | ILA- | ILA115.00 Million | ▼ -5 days |
| 2023 | 252 days | ILA1.82 Billion | ILA7.23 Million/day | ILA- | ILA172.00 Million | ▼ -16 days |
| 2022 | 268 days | ILA1.92 Billion | ILA7.14 Million/day | ILA- | ILA91.00 Million | ▲ +22 days |
| 2021 | 247 days | ILA1.77 Billion | ILA7.16 Million/day | ILA- | ILA91.00 Million | ▲ +48 days |
| 2020 | 199 days | ILA1.18 Billion | ILA5.96 Million/day | ILA- | ILA100.00 Million | ▼ -15 days |
| 2019 | 214 days | ILA1.03 Billion | ILA4.82 Million/day | ILA- | ILA96.00 Million | ▼ -16 days |
| 2018 | 229 days | ILA1.25 Billion | ILA5.43 Million/day | ILA- | ILA92.00 Million | ▲ +41 days |
| 2017 | 189 days | ILA1.20 Billion | ILA6.38 Million/day | ILA- | ILA90.00 Million | ▼ -24 days |
| 2016 | 212 days | ILA1.18 Billion | ILA5.54 Million/day | ILA- | ILA29.00 Million | ▼ -33 days |
| 2015 | 245 days | ILA1.37 Billion | ILA5.61 Million/day | ILA- | ILA87.00 Million | ▲ +14 days |
| 2014 | 231 days | ILA1.27 Billion | ILA5.49 Million/day | ILA- | ILA116.49 Million | ▼ -20 days |
| 2013 | 251 days | ILA1.35 Billion | ILA5.37 Million/day | ILA- | ILA96.39 Million | ▼ -13 days |
| 2012 | 264 days | ILA1.40 Billion | ILA5.28 Million/day | ILA- | ILA172.44 Million | ▼ -77 days |
| 2011 | 342 days | ILA1.64 Billion | ILA4.80 Million/day | ILA- | ILA144.13 Million | ▼ -43 days |
| 2010 | 385 days | ILA1.54 Billion | ILA4.02 Million/day | ILA- | ILA493.20 Million | ▲ +10 days |
| 2009 | 375 days | ILA1.23 Billion | ILA3.29 Million/day | ILA- | ILA167.55 Million | ▲ +45 days |
| 2008 | 329 days | ILA1.42 Billion | ILA4.32 Million/day | ILA- | ILA125.06 Million | ▲ +63 days |
| 2007 | 267 days | ILA1.12 Billion | ILA4.21 Million/day | ILA- | ILA73.66 Million | ▲ +2 days |
| 2006 | 265 days | ILA692.52 Million | ILA2.61 Million/day | ILA- | ILA120.82 Million | ▲ +12 days |
| 2005 | 253 days | ILA620.68 Million | ILA2.46 Million/day | ILA- | ILA58.77 Million | ▲ +14 days |
| 2004 | 239 days | ILA606.05 Million | ILA2.54 Million/day | ILA- | ILA150.33 Million | ▲ +96 days |
| 2003 | 143 days | ILA426.50 Million | ILA2.99 Million/day | ILA- | ILA57.81 Million | ▼ -16 days |
| 2002 | 158 days | ILA493.70 Million | ILA3.12 Million/day | ILA- | ILA16.07 Million | ▼ -44 days |
| 2001 | 203 days | ILA521.05 Million | ILA2.57 Million/day | ILA- | ILA25.50 Million | ▼ -33 days |
| 2000 | 235 days | ILA647.26 Million | ILA2.75 Million/day | ILA- | ILA34.55 Million | — |